Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization

This publication has 15 references indexed in Scilit:

• Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma
  Bone Marrow Transplantation, 1999
• Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer
  Bone Marrow Transplantation, 1999
• Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy
  Bone Marrow Transplantation, 1998
• Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone
  Bone Marrow Transplantation, 1997
• Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1997
• Ifosfamide/Mesna
  Drugs, 1991
• Ifosfamide encephalopathy: a reappraisal
  European Journal of Cancer and Clinical Oncology, 1989
• Phosphorus-31 NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard
  Journal of Medicinal Chemistry, 1989
• GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN
  The Lancet, 1988
• Clinical pharmacology of isophosphamide
  Clinical Pharmacology & Therapeutics, 1974